Literature DB >> 19288144

Exploring metallodrug-protein interactions by mass spectrometry: comparisons between platinum coordination complexes and an organometallic ruthenium compound.

Angela Casini1, Chiara Gabbiani, Elena Michelucci, Giuseppe Pieraccini, Gloriano Moneti, Paul J Dyson, Luigi Messori.   

Abstract

Electrospray ionisation mass spectrometry was used to analyse the reactions of metal compounds with mixtures of selected proteins. Three representative medicinally relevant compounds, cisplatin, transplatin and the organometallic ruthenium compound RAPTA-C, were reacted with a pool of three proteins, ubiquitin, cytochrome c and superoxide dismutase, and the reaction products were analysed using high-resolution mass spectrometry. Highly informative electrospray ionisation mass spectra were acquired following careful optimisation of the experimental conditions. The formation of metal-protein adducts was clearly observed for the three proteins. In addition, valuable information was obtained on the nature of the protein-bound metallofragments, on their distribution among the three different proteins and on the binding kinetics. The platinum compounds were less reactive and considerably less selective in protein binding than RAPTA-C, which showed a high affinity towards ubiquitin and cytochrome c, but not superoxide dismutase. In addition, competition studies between cisplatin and RAPTA-C showed that the two metallodrugs have affinities for the same amino acid residues on protein binding.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19288144     DOI: 10.1007/s00775-009-0489-5

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  43 in total

Review 1.  Antitumor active trans-platinum compounds.

Authors:  Giovanni Natile; Mauro Coluccia
Journal:  Met Ions Biol Syst       Date:  2004

2.  The Orbitrap: a new mass spectrometer.

Authors:  Qizhi Hu; Robert J Noll; Hongyan Li; Alexander Makarov; Mark Hardman; R Graham Cooks
Journal:  J Mass Spectrom       Date:  2005-04       Impact factor: 1.982

3.  Ruthenium (II)-derived organometallic compounds induce cytostatic and cytotoxic effects on mammalian cancer cell lines through p53-dependent and p53-independent mechanisms.

Authors:  C Gaiddon; P Jeannequin; P Bischoff; M Pfeffer; C Sirlin; J P Loeffler
Journal:  J Pharmacol Exp Ther       Date:  2005-09-16       Impact factor: 4.030

Review 4.  Metal-based antitumour drugs in the post genomic era.

Authors:  Paul J Dyson; Gianni Sava
Journal:  Dalton Trans       Date:  2006-03-28       Impact factor: 4.390

Review 5.  From bench to bedside--preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A).

Authors:  Christian G Hartinger; Stefanie Zorbas-Seifried; Michael A Jakupec; Bernd Kynast; Haralabos Zorbas; Bernhard K Keppler
Journal:  J Inorg Biochem       Date:  2006-02-28       Impact factor: 4.155

Review 6.  Metal complex SERMs (selective oestrogen receptor modulators). The influence of different metal units on breast cancer cell antiproliferative effects.

Authors:  Anne Vessières; Siden Top; Wolfgang Beck; Elizabeth Hillard; Gérard Jaouen
Journal:  Dalton Trans       Date:  2005-09-27       Impact factor: 4.390

7.  Interactions of cisplatin and transplatin with proteins. Comparison of binding kinetics, binding sites and reactivity of the Pt-protein adducts of cisplatin and transplatin towards biological nucleophiles.

Authors:  Tal Peleg-Shulman; Yousef Najajreh; Dan Gibson
Journal:  J Inorg Biochem       Date:  2002-07-25       Impact factor: 4.155

8.  Characterisation of cisplatin coordination sites in cellular Escherichia coli DNA-binding proteins by combined biphasic liquid chromatography and ESI tandem mass spectrometry.

Authors:  Joanna Will; William S Sheldrick; Dirk Wolters
Journal:  J Biol Inorg Chem       Date:  2007-12-22       Impact factor: 3.358

Review 9.  DNA modifications by antitumor platinum and ruthenium compounds: their recognition and repair.

Authors:  Viktor Brabec
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2002

10.  Insights into the molecular mechanisms of protein platination from a case study: the reaction of anticancer platinum(II) iminoethers with horse heart cytochrome c.

Authors:  Angela Casini; Chiara Gabbiani; Guido Mastrobuoni; Raffaella Zoe Pellicani; Francesco Paolo Intini; Fabio Arnesano; Giovanni Natile; Gloriano Moneti; Simona Francese; Luigi Messori
Journal:  Biochemistry       Date:  2007-10-09       Impact factor: 3.162

View more
  19 in total

1.  A QM/MM study of the binding of RAPTA ligands to cathepsin B.

Authors:  Antonella Ciancetta; Samuel Genheden; Ulf Ryde
Journal:  J Comput Aided Mol Des       Date:  2011-06-24       Impact factor: 3.686

2.  Mass-spectrometric characterization of cisplatin binding sites on native and denatured ubiquitin.

Authors:  Ting Zhao; Fred L King
Journal:  J Biol Inorg Chem       Date:  2011-03-02       Impact factor: 3.358

3.  Reaction of the Anticancer Organometallic Ruthenium Compound, [(eta-p-Cymene)Ru(ATSC)Cl]PF(6) with Human Serum Albumin.

Authors:  Floyd A Beckford
Journal:  Int J Inorg Chem       Date:  2010-01-01

4.  Mass spectrometric strategies to improve the identification of Pt(II)-modification sites on peptides and proteins.

Authors:  Huilin Li; Jonathon R Snelling; Mark P Barrow; James H Scrivens; Peter J Sadler; Peter B O'Connor
Journal:  J Am Soc Mass Spectrom       Date:  2014-05-21       Impact factor: 3.109

5.  Insights into the binding sites of organometallic ruthenium anticancer compounds on peptides using ultra-high resolution mass spectrometry.

Authors:  Rebecca H Wills; Abraha Habtemariam; Andrea F Lopez-Clavijo; Mark P Barrow; Peter J Sadler; Peter B O'Connor
Journal:  J Am Soc Mass Spectrom       Date:  2014-02-01       Impact factor: 3.109

6.  The interactions of the ruthenium(II)-cymene complexes with lysozyme and cytochrome c.

Authors:  Dragana Stanic-Vucinic; Stefan Nikolic; Katarina Vlajic; Mirjana Radomirovic; Jelena Mihailovic; Tanja Cirkovic Velickovic; Sanja Grguric-Sipka
Journal:  J Biol Inorg Chem       Date:  2020-02-04       Impact factor: 3.358

7.  [Au2(phen(2Me))2(μ-O)2](PF6)2, a Novel Dinuclear Gold(III) Complex Showing Excellent Antiproliferative Properties.

Authors:  Maria A Cinellu; Laura Maiore; Mario Manassero; Angela Casini; Massimiliano Arca; Heinz-Herbert Fiebig; Gerhard Kelter; Elena Michelucci; Giuseppe Pieraccini; Chiara Gabbiani; Luigi Messori
Journal:  ACS Med Chem Lett       Date:  2010-07-02       Impact factor: 4.345

8.  Cytotoxic Profile and Peculiar Reactivity with Biomolecules of a Novel "Rule-Breaker" Iodidoplatinum(II) Complex.

Authors:  Luigi Messori; Angela Casini; Chiara Gabbiani; Elena Michelucci; Leticia Cubo; Carla Ríos-Luci; José M Padrón; Carmen Navarro-Ranninger; Adoracion G Quiroga
Journal:  ACS Med Chem Lett       Date:  2010-07-21       Impact factor: 4.345

9.  Reactivity of anticancer metallodrugs with serum proteins: new insights from size exclusion chromatography-ICP-MS and ESI-MS.

Authors:  Michael Groessl; Mattia Terenghi; Angela Casini; Lisa Elviri; Ryszard Lobinski; Paul J Dyson
Journal:  J Anal At Spectrom       Date:  2010-03       Impact factor: 4.023

10.  Synthesis, Characterisation and In Vitro Anticancer Activity of Catalytically Active Indole-Based Half-Sandwich Complexes.

Authors:  Joan J Soldevila-Barreda; Kehinde B Fawibe; Maria Azmanova; Laia Rafols; Anaïs Pitto-Barry; Uche B Eke; Nicolas P E Barry
Journal:  Molecules       Date:  2020-10-03       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.